Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)
Titel:
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)
Auteur:
Chua, S. Smith, I.E. A'Hern, R.P. Coombes, G.A. Hickish, T.F. Robinson, A.C. Laing, R.W. O'Brien, M.E.R. Ebbs, S.R. Hong, A. Wardley, A. Mughal, T. Verrill, M. Dubois, D. Bliss, J.M.